This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/06/16 - 2:51:00 PM ET (BATS BZX Real-time Price)
Div Yield: --
AMRI Day's Range
AMRI 52 Week Range
AMRI Business Summary
Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia.View AMRI
Albany Molecular Research Inc - AMRI - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Albany Molecular Research Inc as a
Hold with a ratings score of C.
Report Snippet: We rate ALBANY MOLECULAR RESH INC (AMRI) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, generally higher debt management risk and poor profit margins.